Similar Articles
411 Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer
412 Use of the alkaline phosphatase to prealbumin ratio as an independent predictive factor for the prognosis of gastric cancer
413 Identification of key genes controlling cancer stem cell characteristics in gastric cancer
414 Feasibility and nutritional impact of laparoscopic assisted tailored subtotal gastrectomy for middle-third gastric cancer
415 Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway
416 Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysis
417 Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
418 Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
419 Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience
420 Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA